The gonadal steroid 17β-estradiol (E2) rapidly alters glutamatergic neurotransmission, but its direct effect on the AMPA receptor (AMPAR) remains unknown. Live-cell single-molecule imaging experiments revealed that E2 rapidly and dose-dependently alters the surface movement of AMPAR via membrane estrogen receptors with distinct effects on somas and neurites. The effect of E2 on the surface mobility of AMPAR depends on the integrity of the cortical actin network.
Figure 1. Single-molecule imaging of ATTO 488-labeled GluR2-AMPAR and mGluR1 receptors on neurites and on somas of PC12 neurons. (a) Representative trajectories of AMPAR molecules on somas and neurites. Scale bar: 2 µm. (b) The mean square displacement functions and trajectories represent AMPAR molecules with Brownian motion (red) and confined motion (blue). Scale bars: 0.1 µm. The cumulative probability functions of D values of AMPAR (c) and mGluR1 (d) on neurites and on somas are shown (n= 330-500 trajectories). **p<0.01, ***p<0.001
Our PCR results revealed that PC12 neurons express ERβ and GPER1 but not ERα ( Supplementary Fig. 2a ). Although addition of 10 pM diarylpropionitrile (DPN; an ERβ agonist) (10) had no effect on the surface trafficking of GluR2-AMPAR molecules ( Fig. 2d; 
Figure 2. Effect of E2 on the surface trafficking of GluR2-AMPAR and mGluR1. The line graphs depict changes in the diffusion coefficient (D) of GluR2-AMPAR (a) and mGluR1 (b) molecules after vehicle or 100 pM E2 administration at different time points (mean ± SEM, n=100-128 trajectories per time point). (c) Distributions of D (as the percentage of vehicle control) of GluR2-AMPAR (average of 20-minute measurement) in the medium (dRPMI) or after administration of E2 at different concentrations (as the percent of the vehicle treatment expressed as the median ± 25-75%, n= 426-484 trajectories per group). (d) Distributions of D values of AMPAR on neurites in the presence of the estrogen receptor β (ERβ) agonist diarylpropionitrile (DPN), a GPER1 agonist (G1) and a GPER1 antagonist (G15) (expressed as the median ± 25-75%, n=427-468 trajectories). (e) Stochastic optical reconstruction microscopy images depicting immunolabeled AMPAR (magenta) and GPER1 (cyan) molecules on PC12 neurons. The dashed lines delineate the border between the neurite and soma. (f) Distributions of the minimal distance (greater than 500 nm) between GluR2-AMPAR and GPER1 after vehicle or E2 treatment (expressed as the median ± 25-75%, n=203-657).
Scale bar: 2 µm; insert scale bar: 0.5 µm. **p<0.01, ***p<0. 001 Supplementary Fig. 2c ), 100 nM G1 (a GPER1 agonist) (11) mimicked the effect of 100 pM E2 on DAMPAR in neurites (Fig. 2d) without affecting somatic GluR2-AMPAR ( Supplementary   Fig. 2c ). Prior application of 1 µM G15 (a selective GPER1 antagonist) (11) blocked the effect of E2 on both neurites (Fig. 2d) and somas (Supplementary Fig. 2c ). These findings indicate that E2 rapidly decreases the surface trafficking of GluR2-AMPAR molecules via GPER1. In addition, the results of our stochastic optical reconstruction microscopy demonstrated that the median minimal distance between AMPAR and GPER1 molecules (MDAMPAR-GPER1) was approximately 1500 nm ( Fig. 2e, f; Supplementary Fig. 2d ). This result suggests that AMPAR and GPER1 molecules do not form protein complexes in the membrane. To test whether the effect of E2 is accompanied by the redistribution of GPER1 molecules and AMPARs, MDAMPAR-GPER1 was calculated after E2 treatment. Although 100 pM E2 did not have an effect, 100 nM E2 increased MDAMPAR-GPER1 in somas but decreased MDAMPAR-GPER1 in neurites, indicating that AMPARs and GPER1 molecules became closer on neurites than on somas after treatment ( Fig. 2; Supplementary Fig. 2d ). Our findings suggest that GPER1 with bound ligand can remotely alter the surface trafficking of AMPAR and that E2 has a dose-dependent and compartment-specific effect on MDAMPAR-GPER1.
The actin network is essential in the organization of neuronal compartments and plays a crucial role in membrane receptor trafficking (12). We used genetic labeling of cortical actin and structured illumination microscopy super-resolution imaging to reveal the effect of E2 on the cortical actin network. Our results from maximum intensity projections of a series of timelapse images of cortical actin (see Supplementary Methods) revealed that E2 treatment alone did not change cortical actin dynamics in CHO cells ( Fig. 3a and Supplementary Fig. 3a) . To determine the role of cortical actin in the effects of E2, we treated cells with the actin polymerization blocker latrunculin A (latA, 1 µM). The cortical actin network dynamics in CHO cells and the morphology of the cortical actin network in PC12 neurons were disrupted by latA administration (Fig. 3a, b; Supplementary Fig. 3a ; Supplementary Movies 5, 6). In single-molecule imaging experiments, 10 minutes of latA administration increased DAMPAR on somas without affecting DAMPAR on neurites in PC12 neurons (Fig. 3c) . Pretreatment with latA diminished the effect of E2 on the surface trafficking of GluR2-AMPAR molecules on somas (Fig. 3d) . These data indicate that cortical actin is a critical factor in the compartment-specific surface trafficking of AMPAR and plays a pivotal role in the E2-induced effects on the surface diffusion of somatic AMPAR. Our results also suggest that cortical actin is important in the remote effects of GPER1 on AMPAR.
In summary, this study shows the first evidence that E2 decreases the surface movement of GluR2-AMPA in a dose-dependent and compartment-specific manner. E2 alters the surface trafficking of GluR2-AMPA molecules via GPER1, and its action depends on the integrity of the cortical actin network. These observations provide molecular evidence for the remote interaction of GPER1 and AMPAR in neuronal membranes.
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Supplementary figures

Supplementary Figure 1. Characterization of differentiated PC12 cells. (a) Photomicrograph depicting PC12 cells after 4 days of NGF treatment and (b) immunofluorescence staining of microtubule-associated protein 2 (MAP2) and β-III tubulin. Scale bars: 20 µm. (c, d) Representative recording of a whole-cell current-clamp step protocol obtained from PC12 neurons. (c) Application of increasing current steps in PC12 neuronal culture resulted in action potential generation. (d) Trace representing membrane potential changes in PC12 neurons. (e, f) Intensity profiles of a single ATTO 488-labeled GluR2-AMPAR and mGluR1 signal. The arrows indicate single-step photobleaching. (g, h) Histogram showing the intensity value of every spot found in a recording superimposed with a single fitted Gaussian curve (blue line).
Supplementary Figure 2. Effect of estrogen receptor modulation on surface trafficking of AMPAR. (a) Representative PCR gel electrophoresis image depicting the expression of estrogen receptor mRNA (with a lack of expression of estrogen receptor alpha (ERα), estrogen receptor beta (ERβ), and G protein-coupled estrogen receptor 1 (GPER1)) in PC12 neurons. (b) Effect of E2 on the D value of mGluR1 (as the percent of vehicle treatment expressed as the median ± 25-75%, n= 840-860 trajectories per group). (c) Table showing the effect of ERβ agonist (DPN), GPER1 agonist (G1) and GPER1 antagonist (G15) treatment on D (µm 2 /s) values of GluR2-AMPAR molecules (expressed as the median ± 25-75% (in brackets), n=411-525 trajectories). (d) Table of the distributions of each minimal distance interaction type, including indirect (50-100 nm), microdomain (100-500 nm) and remote (500< nm), between GluR2-AMPAR and GPER1 on PC12 neurons after vehicle or E2 treatment (the minimal distance is expressed as the median ± 25-75% (in brackets)).
Supplementary Figure 3. (a) Raw (left) and processed (right) immunofluorescence images obtained with structured illumination microscopy depicting the
Supplementary Movies
Movie S1, S2. Movies of ATTO 488-labeled GluR2-AMPAR on the neurites (S1) and somas 
Supplementary Methods
Cell culture and neuronal differentiation
For single-molecule imaging of glutamate receptors, rat pheochromocytoma cells (PC12, Sigma-Aldrich) were differentiated into neurons. PC12 cells were plated at a density of 2x10 3 cells/cm 2 on collagen IV-coated 35-mm glass-bottom dishes (MatTek Corporation) in phenol red-free RPMI 1640 medium supplemented with 10% HS, 5% FBS and 2 mM Lglutamine (culture RPMI, cRPMI). Twelve hours after plating, the medium was replaced with phenol red-free RPMI 1640 medium supplemented with 1% HS, 2 mM L-glutamine and 50 ng/ml nerve growth factor (NGF-2.5S, Sigma-Aldrich) (differentiation RPMI, dRPMI). The cells were fed with dRPMI after 2 days and used for imaging after 4 days of differentiation ( Supplementary Fig. 1a ). CHO cells were cultured in phenol red-free F12 medium supplemented with 10% FBS and 2 mM L-glutamine (culture F12, cF12) at 37°C in an incubator at 95% relative humidity with 5% CO2 and plated on glass-bottom dishes (MatTek Corporation) 24 hours before the experiments.
Validation of neuronal differentiation with immunohistochemistry and electrophysiology
To Fig. 1b ).
The electrophysiological properties of neurons differentiated from PC12 cells were tested using whole-cell patch-clamp recording. Patch pipettes (1.5 mm outer diameter and 1.1 inner diameter) with a resistance of 6 MΩ were pulled from borosilicate glass capillaries with a micropipette puller (Sutter Instruments). The pipette recording solution contained (in mM) 10
KCl, 130 K-gluconate, 1.8 NaCl, 0.2 EGTA, 10 HEPES, and 2 Na-ATP, and the pH was adjusted to 7.3 with KOH. All recordings were performed at 32°C in a chamber perfused with oxygenated artificial cerebrospinal fluid (ACSF) containing (in mM) 2.5 KCl, 10 glucose, 126
NaCl, 1.25 NaH2PO4, 2 MgCl2, 2 CaCl2, and 26 NaHCO3. Whole-cell recordings were made with an Axopatch 700B amplifier (Molecular Devices) using an upright microscope (Nikon Eclipse FN1) equipped with infrared differential interference contrast (IR-DIC) optics. Cells with access resistance below 20 MΩ were used for analysis. Signals were low-pass filtered at 5 kHz and digitized at 20 kHz (Digidata 1550B, Molecular Devices). Acquisition and subsequent analysis of the data were performed using Clampex9 and Clampfit software (Axon Instruments). Traces were plotted using Origin8 software (MicroCal Software, Northampton, MA) ( Supplementary Fig. 1c ).
Detection of estrogen receptors
Expression of estrogen receptor α (ERα), estrogen receptor β (ERβ) and the membrane estrogen receptor G protein-coupled estrogen receptor 1 (GPER1) was examined in neurons differentiated from PC12 cells. Total RNA was extracted from neurons with a conventional TRIzol (Thermo Fisher Scientific)-based protocol, and cDNA was constructed using a HighCapacity RNA to cDNA Kit (Thermo Fisher Scientific). For PCR, the following primers were Fig. 2a ).
Glutamate receptor labeling in live neurons
To detect AMPA-GluR2 and mGluR1 molecules in the plasma membranes of PC12 neurons, live-cell immunocytochemistry was performed. Before single-molecule imaging, PC12 neurons were incubated in dRPMI with ATTO 488-labeled antibodies directed against the extracellular N-terminal domain of rat GluR2 (1:100, Alomone Labs) or against the extracellular N-terminal domain of rat mGluR1 (1:100, Alomone Labs) at 37°C for 6 minutes. The specificity of the antibodies was tested with control peptides (GluA2179-193 peptide and mGluR1501-516 peptide, Alomone Labs), and no immunoreactivity was observed.
Drug application and cell viability detection
The following drugs were applied immediately before imaging in dRPMI for neurons:
17β-estradiol (E2, Sigma-Aldrich, 100 pM in 10 -5 % EtOH and 100 nM in 10 -3 % EtOH); G1, a selective GPER1 agonist (Tocris, 100 pM in 10 -3 % DMSO and 100 nM in 10 -5 % DMSO); and diarylpropionitrile (DPN), a selective ER-β agonist (Tocris, 10 pM in 2x10 -5 % DMSO). To block GPER1, neurons were incubated in dRPMI containing G15, a selective GPER1
antagonist (Tocris, 1 µM in 2x10 -3 % DMSO) for 10 minutes before E2 application and imaging.
The actin polymerization inhibitor latrunculin A (latA, Sigma-Aldrich, 1 µM in 0.1% DMSO)
was applied for 5 minutes before E2 addition and imaging. CHO cells were treated with latA (1 µM) or E2 (100 pM or 100 nM) in cF12 for 15 minutes.
The viability of the cells was tested after latA treatment with a LIVE/DEAD viability/Cytotoxicity Kit (Thermo Fisher Scientific) ( Supplementary Fig. 3b, c) 
Single-molecule imaging of glutamate receptors using total internal reflection fluorescence microscopy (TIRFM)
Single-molecule imaging of labeled glutamate receptors was carried out on an Olympus The fluorescence intensity versus time function showed one-step photobleaching representing single ATTO 488 fluorophores. The peak intensity of the intensity spot frequency histogram was similar to that of the step size for photobleaching ( Supplementary Fig. 1d, e) .
These results suggest that most of the spots represented single fluorophores and single receptors.
Diffusion coefficient (D) calculation with the maximum likelihood method
To calculate D for moving molecules, we first determined the immobile trajectories with MATLAB-based software (TrackArt) (1). Since a zero or negative slope of a line fitted to the . This likelihood function was maximized by a numerical method implemented in MATLAB.
Colocalization analysis of AMPAR and GPER1 using stochastic optical reconstruction microscopy (STORM)
To examine the probability of interaction between AMPAR and GPER1, STORM imaging was performed. PC12 cells were plated onto poly-D-lysine (PDL)-and laminin-coated coverslips (5) and differentiated into neurons as described above. The neurons were incubated in dRPMI containing vehicle (EtOH) or E2 (100 pM or 100 nM) at 37°C for 10 minutes. center of mass were used to determine the distances between AMPAR and GPER1 molecules (7) . The minimal distances between AMPARs and the closest GPER1 molecules were plotted for each treatment ( Fig. 2e; Supplementary Fig. 2c ). Interactions based on distance were defined as indirect (50-100 nm), microdomain (100-500 nm) (8) and remote (500< nm) ( Supplementary   Fig. 2c ).
Imaging and analysis of cortical actin network dynamics and morphology using structured illumination microscopy (SIM) and CLSM
Cortical actin dynamics and their response to E2 or latA were examined in live CHO cells transfected (with Lipofectamine 3000, Thermo Fisher Scientific) with a genetically encoded construct specific for filamentous actin, mEmerald-Lifeact-7 (a gift from Michael
Davidson, Addgene plasmid #54148). Time-lapse imaging was carried out using a SIM system (Zeiss Elyra S1) equipped with a plan apochromat oil immersion objective (100X, NA 1.46, Zeiss) (Supplementary Movies). The wavelength of the excitation laser was 488 nm, and the emission filter was a 495-550-nm bandpass filter. Time-lapse image sequences of 50 frames were acquired at a frame rate of 0.25 Hz before and after treatment of each cell. Image processing was performed with the Fiji package of ImageJ software (9) . The images were bleach corrected, background-subtracted and thresholded. In the thresholded image sequence, the actin signals and the background appeared as white and black pixels, respectively.
( Supplementary Fig. 3a) . Time-lapse image sequences (50 frames) were defined as image stacks, with each frame representing one slice of the stack. We applied maximal-intensity Zprojection for the image stacks to compress them to a single 2D image. The cortical actin network was characterized quantitatively by the total number of white pixels on the 2D plane (TNWP). To delineate the moving elements of the cortical actin network, static components (mainly stress fibers) were eliminated by subtracting the TNWP of the first 30 images from the TNWP of the whole stack. The pixels were counted in one ROI. They were selected to contain the fewest stress fibers and other relatively static structures possible while covering a large portion (usually more than half) of the cell. ROIs of the same size were used for images before and after treatment.
To validate the effect of latA on neurons, the morphology of the cortical actin network of fixed PC12 neurons was examined after latA administration. on each cell were selected, and the average integrated density was calculated for 3 latA-treated and 3 vehicle-treated PC12 neurons (Fig. 3b) .
